[1]
Muhammad W. Saif, MD, “Safety and Efficacy of Biweekly Gemcitabine in Combination with Capecitabine in Elderly and Frail Patients with Resected Pancreatic Cancer”, POJ, vol. 6, no. 1, pp. 7–12, Sep. 2025.